IPR2022-00056 - Biofrontera Pharma GMBH et al. v. Bell Northern Research LLC et al.

Details
PATENT NUMBER
10357567 Medical
APPL. NUMBER
15869164
PETITIONER
Biofrontera Pharma GMBH
Biofrontera Inc
Biofrontera Bioscience GMBH
Biofrontera AG
Defensive Aggregators
PATENT OWNER
Bell Northern Research LLC
Dusa Pharmaceuticals Inc
Operating Company
STATUS
Settlement
FILING DATE
2021-10-19
INSTITUTION DATE
N/A
TERMINATION DATE
2022-01-24
PET. COUNSEL
McKool Smith PC
P.O. COUNSEL
Fish & Richardson P.C.
AUTHOR JUDGE
Timeline
Petition
Notice of Filing Date
Motion to Terminate
Motion to Terminate
Final Decision
Oct
Nov
Dec
2022
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2023
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2024
Feb
Mar
Docket
Paper No.
Date
Party
Type
Name
12021-10-19PetitionerPetitionPetition for Inter Partes Review Under 35 U.S.C. 312
22021-10-19PetitionerPower of AttorneyPetitioner's Power of Attorney
10012021-10-19PetitionerU.S. Patent No. 10,357,567
10022021-10-19PetitionerExcerpts from U.S. Patent Application No. 15/869,164
10032021-10-19PetitionerDeclaration of Dr. Howard Rogers MD, PHD
10042021-10-19PetitionerCV of Dr. Howard Rogers MD, PHD
10052021-10-19PetitionerPCT Publication No. WO 96/06602 (Noven Pharma)
10062021-10-19PetitionerSakamoto FH, Torezan L, Anderson RR. Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part II. Understanding parameters for acne treatment with photodynamic therapy. J Am Acad Dermatol. 2010 Aug;63(2):195-211
10072021-10-19PetitionerBerardesca E, Vignoli GP, Fideli D, Maibach H. Effect of occlusive dressings on the stratum corneum water holding capacity. The American Journal of the Medical Sciences. 1992 Jul;304(1):25-28
10082021-10-19PetitionerFauteck JD, Ackermann G, Birkel M, Breuer M, Moor AC, Ebeling A, Ortland C. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses.
10092021-10-19PetitionerU.S. Patent Publication No. US2009/0324727 A1 (Biofrontera)
10102021-10-19PetitionerAmeluz�� Prescribing Information (2016)
10112021-10-19PetitionerLevulan�� Label (2002)
10122021-10-19PetitionerBlu-U�� Operating Manual (2006)
10132021-10-19PetitionerWilley A, Anderson RR, Sakamoto FH. Temperature-modulated photodynamic therapy for the treatment of actinic keratosis on the extremities. Dermatologic Surgery. 2014 Oct;40(10):1094- 1102
10142021-10-19PetitionerCalderhead RG. Light-emitting diode phototherapy in dermatological practice in lasers in dermatology and medicine. Lasers in Dermatology and Medicine. 2011 Aug:231-265
10152021-10-19PetitionerPalm M., Goldman PM. Aminolevulinic acid: actinic keratosis and photorejuvenation. In: Gold M.H., editor. Photodynamic Therapy in Dermatology. Springer Science and Business Media, LLC. 2011 Nov:5-30
10162021-10-19PetitionerMacCormack MA. Photodynamic therapy in dermatology: an update on applications and outcomes. Semin Cutan Med Surg. 2008 Mar;27(1):52-62
10172021-10-19PetitionerSotiriou E, Apalla Z, Maliamani F, Zaparas N, Panagiotidou D, Ioannides D. Intraindividual, right-left comparison of topical 5- aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.
10182021-10-19PetitionerBissonnette R. Photodynamic therapy. In: Gold M.H., editor. Photodynamic Therapy in Dermatology. Springer Science and Business Media, LLC; New York, NY, USA: 2011. pp. 221���229
10192021-10-19PetitionerMcLaren G. Photodynamic therapy. In; Pfenninger and Fowler's procedures for primary care. Third Ed. Mosby Elsevier; Philadelphia, PA: 2011. pp 397-400
10202021-10-19PetitionerHarris DR. Percutaneous absorption and the surface area of occluded skin: a scanning electron microscopic study. British Journal of Dermatology. 1974; 91(27-32)
10212021-10-19PetitionerLevulan�� Label (2009)
10222021-10-19PetitionerWachowska et al., Aminolevulinic acid (ALA) as a prodrug in photodynamic therapy of cancer. Molecules. 2011 May; 16(5): 4140-4164
10232021-10-19PetitionerAgostinis et al. Photodynamic therapy of cancer: an update. CA: A Cancer Journal for Clinicians. 2011 May; 61(4):250-2
10242021-10-19PetitionerWolf P., Rieger E. and Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5- aminolevulinic acid: an alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?
10252021-10-19PetitionerJeffes E., McCullough J., Weinstein G., Fergin P., Nelson J., Shull T., Simpson K., Bukaty L., Hoffman W., Fong N. Photodynamic therapy of actinic keratosis with topical 5- aminolevulinic acid. A pilot dose-ranging study. Arch Dermatol. 1997
10262021-10-19PetitionerHongcharu W., Taylor C., Chang, Y., Aghasi, D., Suthamjariya, K., Anderson, R. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000 Aug;115(2):183-92
10272021-10-19PetitionerOzog, D., Rkein, A., Fabi, S., Gold M., Goldman, M., Lowe, N., Martin, G., Munavalli, G. Photodynamic therapy: A clinical consensus guide. Dermatol Surg. 2016 Jul;42(7):804-27
10282021-10-19PetitionerAktilite CL128 Operators Manual with Metvixia
10292021-10-19PetitionerDUSA Levulan Press Release
10302021-10-19PetitionerEuropean Medicines Agency CHMP Assessment Report (excerpts)
10312021-10-19PetitionerAffidavit of Duncan Hall
10322021-10-19PetitionerWilley Pubmed Website Database Listing
10332021-10-19PetitionerSotiriou Pubmed Website Database Listing
10342021-10-19PetitionerFauteck Europe PMC Website Database Listing
10352021-10-19PetitionerRick K, Sroka R, Stepp H, Kriegmair M, Huber RM, Jacob K, Baumgartner R. Pharmacokinetics of 5-aminolevulinic acidinduced protoporphyrin IX in skin and blood. J Photochem Photobiol B. 1997 Oct;40(3):313-9
10362021-10-19PetitionerInternational Patent Reviews, LLC review of U.S. Patent No. 10,357,567 dated July 26, 2021
10372021-10-19PetitionerNews article entitled DUSA Pharmaceuticals To Pay U.S. $20.75 Million To Settle False Claims Act Allegations Relating To Promotion Of Unsupported Drug Administration Process
32021-10-29BoardNotice of Filing DateNotice: Notice filing date accorded
42021-11-09Potential Patent OwnerMandatory NoticePatent Owner's Mandatory Notices
52021-11-09Potential Patent OwnerPower of AttorneyPatent Owner's Power of Attorney
62021-12-03PetitionerMotion to TerminateUnopposed Motion to Dismiss Petition for Inter Partes Review
72021-12-28BoardOtherDenying, without Prejudice, Petitioner Motion to Dismiss the Petition 37 C.F.R. §§ 42.5(a), 42.71(a), 42.74(b)
82022-01-18PetitionerMotion to TerminateRenewed Unopposed Motion to Dismiss Petition for Inter Partes Review
92022-01-18PetitionerOtherJoint Request that Settlement Agreement Be Treated as Business Confidential Information and Be Kept Separate Pursuant to 35 U.S.C. �� 317(b) and 37 C.F.R. �� 42.74(c)
102022-01-24BoardFinal DecisionTermination Decision: Pre-DI dismissal
112022-01-28PetitionerOtherRequest for Refund of Post-Institution Fees
122022-01-31BoardOtherNotice: refund approved
Grounds Asserted

Not a member? Sign up for free!